193 related articles for article (PubMed ID: 1718389)
21. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey.
Lauria F; Rondelli D; Zinzani PL; Bocchia M; Marotta G; Salvucci M; Raspadori D; Ventura MA; Birtolo S; Forconi F; Tura S
Leukemia; 1997 May; 11(5):629-32. PubMed ID: 9180283
[TBL] [Abstract][Full Text] [Related]
22. Treatment of hairy-cell leukemia: current views.
Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A
Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384
[TBL] [Abstract][Full Text] [Related]
23. 2-CdA in the treatment of hairy cell leukaemia.
Abhyankar D; Bajpai S; Saikia T; Gopal R; Nair CN; Advani SH
J Assoc Physicians India; 2001 Aug; 49():785-7. PubMed ID: 11837464
[TBL] [Abstract][Full Text] [Related]
24. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
[TBL] [Abstract][Full Text] [Related]
25. [Hairy cell leukemia and its treatment with 2-chlorodeoxyadenosine (2-CdA)].
Pawelski S
Acta Haematol Pol; 1995; 26(2):139-43. PubMed ID: 7653218
[TBL] [Abstract][Full Text] [Related]
26. Bone-marrow biopsy in hairy cell leukaemia (HCL) patients. Histological and immunohistological analysis of 46 cases treated with different therapies.
Pileri S; Sabattini E; Poggi S; Merla E; Raspadori D; Benfenati D; Rondelli D; Benni M; Ventura MA; Falini B
Leuk Lymphoma; 1994; 14 Suppl 1():67-71. PubMed ID: 7820056
[TBL] [Abstract][Full Text] [Related]
27. Optimal treatment for untreated patients with hairy cell leukemia?
Troussard X; Flandrin G
J Clin Oncol; 1995 Oct; 13(10):2677-9. PubMed ID: 7595722
[No Abstract] [Full Text] [Related]
28. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V
Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616
[TBL] [Abstract][Full Text] [Related]
29. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389
[TBL] [Abstract][Full Text] [Related]
30. Red cell distribution width (RDW) as a marker of disease activity in patients with hairy cell leukemia.
Chrobák L; Zák P; Podzimek K; Stránský P
Acta Medica (Hradec Kralove); 1998; 41(1):23-6. PubMed ID: 9588069
[TBL] [Abstract][Full Text] [Related]
31. Combined treatment with splenectomy and cladribine in hairy cell leukemia in Taiwan: a clinicopathologic study of 5 cases.
Yu YB; Li CY; Chen CC; You JY; Chau WK; Hsu HC; Gau JP; Chen PM; Ho CH
J Chin Med Assoc; 2007 Dec; 70(12):551-5. PubMed ID: 18194897
[TBL] [Abstract][Full Text] [Related]
32. [Role of alpha-interferon in the treatment of hairy cell leukemia].
Vedantam S; Gamliel Kh; Golomb KhM
Gematol Transfuziol; 1993; 38(8):3-7. PubMed ID: 8307302
[TBL] [Abstract][Full Text] [Related]
33. Advances in the treatment of hairy-cell leukaemia.
Mey U; Strehl J; Gorschlüter M; Ziske C; Glasmacher A; Pralle H; Schmidt-Wolf I
Lancet Oncol; 2003 Feb; 4(2):86-94. PubMed ID: 12573350
[TBL] [Abstract][Full Text] [Related]
34. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
Glaspy JA; Souza L; Scates S; Narachi M; Blatt L; Ambersley J; Golde DW
J Immunother (1991); 1992 Apr; 11(3):198-208. PubMed ID: 1381218
[TBL] [Abstract][Full Text] [Related]
35. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
Yang MH; Ho CH
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
[TBL] [Abstract][Full Text] [Related]
36. [A new effective therapy of hairy cell leukemia and other lymphoproliferative diseases].
Juliusson G; Liliemark J
Lakartidningen; 1991 Aug; 88(35):2746-9. PubMed ID: 1680209
[No Abstract] [Full Text] [Related]
37. Treatment options for hairy-cell leukemia.
Golomb HM; Ellis E
Semin Oncol; 1991 Oct; 18(5 Suppl 7):7-11. PubMed ID: 1719643
[TBL] [Abstract][Full Text] [Related]
38. Hairy cell leukaemia: the role of alpha interferon.
Platanias LC; Ratain MJ
Eur J Cancer; 1991; 27 Suppl 4():S53-7. PubMed ID: 1799481
[TBL] [Abstract][Full Text] [Related]
39. Complete remissions in hairy cell leukemia with 2-chlorodeoxyadenosine after failure with 2'-deoxycoformycin.
Saven A; Piro LD
Ann Intern Med; 1993 Aug; 119(4):278-83. PubMed ID: 8101069
[TBL] [Abstract][Full Text] [Related]
40. Splenectomy and treatments of historical interest.
Zakarija A; Peterson LC; Tallman MS
Best Pract Res Clin Haematol; 2003 Mar; 16(1):57-68. PubMed ID: 12670465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
